
    
      This clinical trial is to assess the efficacy of plant-based bioequivalent Nitric Oxide
      supplement for improving blood pressure and endothelial reactivity over a 12 weeks
      intervention period in individuals with metabolic syndrome. The study also examines the
      effect of plant-based bioequivalent Nitric Oxide supplement on other markers of
      cardiovascular function and cardiovascular disease risk including Total, LDL and
      HDL-Cholesterol, Triglycerides, and a multitude of inflammatory markers.
    
  